Inclisiran: a new milestone on the PCSK9 road to tackle cardiovascular risk [PDF]
, 2021 Gaetano Santulli +2 more
openalex +1 more source
Inclisiran: testing a population health management methodology to implement a novel lipid treatment [PDF]
, 2021 openalex +1 more source
Efficacy and safety of inclisiran in patients with established cerebrovascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised clinical trials [PDF]
, 2021 Wolfgang Köenig +9 more
openalex +1 more source
Clinical Efficacy and Cholesterol-Lowering Effects of Inclisiran [PDF]
, 2021 Muhammad Danial bin Daud
openalex +1 more source
Inclisiran, ARN interferente pequeño: un nuevo enfoque para el tratamiento del colesterol [PDF]
, 2022 Maria C. Fragozo-Ramos +5 more
openalex +1 more source
Harnessing RNA Interference for Cholesterol Lowering: The Bench‐to‐Bedside Story of Inclisiran [PDF]
Michael J. Wilkinson +3 more
openalex +1 more source
Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial [PDF]
R. Scott Wright +11 more
openalex +1 more source